RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Integra Lifesciences Holdings Stock

Integra Lifesciences Holdings P/S 2024

Integra Lifesciences Holdings P/S

1.5

Ticker

IART

ISIN

US4579852082

WKN

897013

As of Jul 17, 2024, Integra Lifesciences Holdings's P/S ratio stood at 1.5, a -25% change from the 2 P/S ratio recorded in the previous year.

The Integra Lifesciences Holdings P/S history

Integra Lifesciences Holdings Aktienanalyse

What does Integra Lifesciences Holdings do?

Integra Lifesciences Holdings Corp is a multinational manufacturer and provider of medical devices, implants, and instruments. The company is headquartered in Plainsboro, New Jersey and was founded in 1989. Integra Lifesciences specializes in the development and marketing of products for orthopedic surgery, neurosurgery, and plastic and reconstructive surgery. The company has a wide range of products that have been constantly improved and expanded over the years. The history of Integra Lifesciences is characterized by continuous expansion through the acquisition of other companies. In 1996, the company acquired Confluent Surgical, which allowed them to enter the tissue adhesive sector. In the following years, several companies were acquired, including Depuy Orthopaedics, Kaye Surgical, and SeaSpine Holdings. Each acquisition has contributed to Integra Lifesciences being able to offer its customers an extensive product portfolio that meets all requirements. Integra Lifesciences has a diversified business model that focuses on four different divisions: anesthesia, neurosurgery, plastic and reconstructive surgery, and orthopedic surgery. Each division has its own range of products that are tailored to the specific requirements of its customers. Integra Lifesciences supplies high-quality medical instruments that are valued by surgeons around the world. These include products such as bone cement, implants, skull plates, bone screws, tissue adhesives, and spinal fusion devices. All products from Integra Lifesciences aim to improve patient care and enhance patients' quality of life. The anesthesia division offers a wide range of products and technologies that improve the administration of anesthesia and enable optimal patient care. In addition to traditional products such as anesthesia masks and tubes, Integra Lifesciences also develops innovative products such as disposable ventilation systems that can increase safety and efficiency. The neurosurgery division offers a wide range of devices and implants for the treatment of brain and spinal cord conditions. The product range includes skull plates, bone connectors, and devices for performing brain surgeries. In the plastic and reconstructive surgery division, Integra Lifesciences offers products for the treatment of burns and the reconstruction of bones and soft tissues. The company has a wide range of products, including skin grafts, scar treatment, and liposuction. Orthopedic surgery is one of the established divisions at Integra Lifesciences, offering a wide range of products for the treatment of bone and joint problems. The company provides implants and instruments for all types of orthopedic procedures, including hip and knee replacements, spinal fusion, and limb reconstruction. Overall, Integra Lifesciences Holdings Corp is a leading manufacturer of medical devices, implants, and instruments specializing in the fields of orthopedics, neurosurgery, and plastic and reconstructive surgery. With its comprehensive product range and innovative technologies, Integra Lifesciences has gained a leading position in the industry, providing its customers worldwide with the highest quality and safety. Integra Lifesciences Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Integra Lifesciences Holdings's P/S Ratio

Integra Lifesciences Holdings's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Integra Lifesciences Holdings's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Integra Lifesciences Holdings's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Integra Lifesciences Holdings’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Integra Lifesciences Holdings stock

What is the price-to-earnings ratio of Integra Lifesciences Holdings?

The price-earnings ratio of Integra Lifesciences Holdings is currently 1.5.

How has the price-earnings ratio of Integra Lifesciences Holdings changed compared to last year?

The price-to-earnings ratio of Integra Lifesciences Holdings has increased by -25% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Integra Lifesciences Holdings high compared to other companies?

Yes, the price-to-earnings ratio of Integra Lifesciences Holdings is high compared to other companies.

How does an increase in the price-earnings ratio of Integra Lifesciences Holdings affect the company?

An increase in the price-earnings ratio of Integra Lifesciences Holdings would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Integra Lifesciences Holdings affect the company?

A decrease in the price-earnings ratio of Integra Lifesciences Holdings would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Integra Lifesciences Holdings?

Some factors that influence the price-earnings ratio of Integra Lifesciences Holdings are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Integra Lifesciences Holdings pay?

Over the past 12 months, Integra Lifesciences Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Integra Lifesciences Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Integra Lifesciences Holdings?

The current dividend yield of Integra Lifesciences Holdings is .

When does Integra Lifesciences Holdings pay dividends?

Integra Lifesciences Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Integra Lifesciences Holdings?

Integra Lifesciences Holdings paid dividends every year for the past 0 years.

What is the dividend of Integra Lifesciences Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Integra Lifesciences Holdings located?

Integra Lifesciences Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Integra Lifesciences Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Integra Lifesciences Holdings from 7/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/17/2024.

When did Integra Lifesciences Holdings pay the last dividend?

The last dividend was paid out on 7/17/2024.

What was the dividend of Integra Lifesciences Holdings in the year 2023?

In the year 2023, Integra Lifesciences Holdings distributed 0 USD as dividends.

In which currency does Integra Lifesciences Holdings pay out the dividend?

The dividends of Integra Lifesciences Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Integra Lifesciences Holdings

Our stock analysis for Integra Lifesciences Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integra Lifesciences Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.